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ABSTRACT The recent human coronavirus disease (COVID-19) is a respiratory infection caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the effects of COVID-19 in pulmonary
tissues, chest radiography imaging plays an important role in the screening, early detection, and monitoring
of the suspected individuals. Hence, as the pandemic of COVID-19 progresses, there will be a greater reliance
on the use of portable equipment for the acquisition of chest X-ray images due to its accessibility, widespread
availability, and benefits regarding to infection control issues, minimizing the risk of cross-contamination.
This work presents novel fully automatic approaches specifically tailored for the classification of chest
X-ray images acquired by portable equipment into 3 different clinical categories: normal, pathological, and
COVID-19. For this purpose, 3 complementary deep learning approaches based on a densely convolutional
network architecture are herein presented. The joint response of all the approaches allows to enhance
the differentiation between patients infected with COVID-19, patients with other diseases that manifest
characteristics similar to COVID-19 and normal cases. The proposed approaches were validated over a
dataset specifically retrieved for this research. Despite the poor quality of the chest X-ray images that is
inherent to the nature of the portable equipment, the proposed approaches provided global accuracy values
of 79.62%, 90.27% and 79.86%, respectively, allowing a reliable analysis of portable radiographs to facilitate
the clinical decision-making process.
INDEX TERMS Chest X-ray imaging, COVID-19, deep learning, X-ray portable device.
I. INTRODUCTION
Coronavirus disease 2019 (COVID-19) is a respiratory infec-
tion caused by the novel coronavirus severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2) [1]. It initially
emerged in late December 2019 as a cluster of cases of
pneumonia with unknown cause, rapidly spreading world-
wide [2]. Given the alarming levels of spread across the
world and its severity, theWorld Health Organization (WHO)
The associate editor coordinating the review of this manuscript and
approving it for publication was Derek Abbott .
declared the outbreak of COVID-19 as a global pandemic on
11 March 2020, with more than 118,000 confirmed cases,
including 4,291 deaths reported in 114 countries [3]. By
August the 29th 2020, it had affected more than 213 coun-
tries/regions, with 24,537,560 confirmed cases, including
832,879 deaths, reported to the World Health Organization
(WHO) [4].
Among the observable symptoms, the infection can
manifest fever, coughing, shortness of breath, pneumonia,
and acute respiratory distress syndrome, with severe cases
associated with intensive care unit admission and high
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mortality [5]. The severity of the disease is related to
advanced age and co-morbidities such as chronic heart and
lung disease [6]. Additionally, the virus is highly contagious,
spreading efficiently by human to human transmission via
droplets or close contact [7], with an R0 ≥ 3, that is, on aver-
age, each infected person is capable of transmitting the virus
to 3 other people [6]. Therefore, the COVID-19 is considered
as a public health emergency, and according to the key areas
described by the WHO, the early diagnosis is a priority
in order to break the chain of transmission and, therefore,
control the spread of the virus [4].
During the last decades, chest radiography imaging has
been a diagnostic tool commonly used in the clinical prac-
tice to examine abnormalities in the cardiothoracic region,
in order to detect and monitor the evolution of several pul-
monary diseases, such as emphysema, chronic bronchitis,
pulmonary fibrosis, lung cancer or pneumonia, among others
[8]–[11]. Regarding the COVID-19 disease, several mani-
festations and patterns of lung abnormality were identified
in chest X-ray images such as bilateral abnormalities, inter-
stitial abnormalities, lung consolidation, and ground-glass
opacities [12]. Therefore, the analysis of chest X-ray images
of the suspected individuals presents a remarkable potential
for screening processes and early diagnosis of COVID-19
disease [13], even more when it is known that Polymerase
Chain Reaction (PCR) studies, despite their effectiveness,
have a percentage of false negatives, being therefore the
radiological analysis another complementary tool to support
and confirm the diagnosis of these patients [14]. In this
context, the specialist’s experience is essential for the iden-
tification and characterization of biomarkers associated with
COVID-19, as well as the differentiation from other clinical
findings related to other respiratory diseases with similar
characteristics, as pneumonia. However, the subjective appre-
ciation of the clinical biomarkers and the variety of X-ray
images entail an inter and intra expert variability that affects
the repeatability of the manual evaluation of chest X-ray
images. Besides the subjectivity, the manual characterization
is a tedious and time-consuming task. Therefore, a fully
automatic system for the analysis of chest X-ray images
identifying normal, pathological or specific COVID-19 cases
would reduce the workload of the clinical staff allowing
a reliable and repeatable evaluation to support the clinical
decision-making process.
Over recent years, deep learning techniques have demon-
strated their potential, effectiveness, and versatility, position-
ing themselves as benchmarks in solving a large number of
problems in multiple fields, highlighting computer vision.
The advances in terms of computational capabilities as well
as the availability of large labeled datasets have promoted the
use of deep learning techniques in the field of medical imag-
ing [15]. In particular, the potential of these techniques has
been exploited for the detection and assessment of cardiotho-
racic and pulmonary abnormalities in chest X-ray imaging,
one of the most widely used imaging tests in medical practice
[16], [17]. Therefore, Anthimopoulos et al. [18] present a
deep CNN (Convolutional Neural Network) to classify lung
image patches into 7 categories considering 6 different pat-
terns of interstitial lung diseases as well as healthy tissue.
In the work of Campo et al. [19], the authors present a method
based on a CNN for the quantification of the emphysema per-
centage on simulated chest X-ray images. Jaiswal et al. [20]
propose a deep neural network that incorporates global and
local features for the identification of pneumonia in chest
X-ray images. Pasa et al. [21] explore deep network architec-
tures tailored to tuberculosis diagnosis. Other works in this
field incorporate transfer learning techniques in order to per-
form an effective learning stage over a limited dataset using
transferring features extracted from other larger datasets in
the same domain. Thus, Ausawalaithong et al. [11] presents
a method based on a DenseNet-121 along with multi-transfer
learning in order to classify lung cancer in chest X-ray
images. The method consists of a first stage aimed at trans-
ferring the model from general image domain to chest X-ray
domain, allowing the classification between chest X-ray
images with nodules or without nodules. After that, the sec-
ond stage of transfer learning is used for the specialization of
lung cancer, allowing the classification between chest X-ray
images withmalignant nodules or without malignant nodules.
The entire process provides a model more specific for the
lung cancer assessment. In the work of Chouhan et al. [22],
the authors present a novel ensemble approach based
on the transfer learning of five different neural network
architectures.
In the context of the global pandemic originated by the
COVID-19 disease, given the relevance of the topic, during
the last months, several authors proposed computational
approaches for the COVID-19 classification on chest X-ray
images using deep learning techniques. As reference,
Apostolopoulos et al. [23] explore the possibility of extract-
ing representative COVID-19 biomarkers from chest X-ray
images by means of deep learning strategies. In the work of
Wang et al. [24], the authors present COVID-Net, a deep con-
volutional neural network tailored for detecting COVID-19
cases from chest X-ray images. Hammoudi et al. [25]
proposed a deep learning method applied to chest X-ray
images to identify health and pneumonia cases, differenti-
ating between bacterial or viral origin, assuming that, during
the epidemic season, if the origin of pneumonia is viral, there
is a high probability of being a positive COVID-19 case.
Hemdan et al. [26] proposed COVIDX-Net, an approach
comprising seven convolutional neural networks for
the diagnosis of COVID-19 in chest X-ray images.
De Moura et al. [27] presented several fully automatic deep
convolutional approaches for the classification and study of
COVID-19, common pneumonia and healthy chest X-ray
images. In the work of Zhang et al. [28], the authors proposed
a deep anomaly detection model for COVID-19 screening
on chest X-ray images. Ozturk et al. [29] proposed a deep
learning model that provides heatmaps highlighting impor-
tant areas in the chest X-ray images to help the specialists
to locate the affected regions for the early detection of the
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COVID-19 disease. Shelke et al. [30] present a method for
the classification of chest X-ray images into the classes nor-
mal, pneumonia, tuberculosis, and COVID-19. In the case of
COVID-19, additional categorization into mild, medium, and
severe is also provided. In the work of Yoo et al. [31],
the authors propose a deep learning-based decision-tree clas-
sifier for the detection of COVID-19 in chest X-ray images.
It is composed of a first decision tree that classifies the
images as normal or abnormal, then, a second tree identi-
fies the abnormal images that present signs of tuberculosis,
whereas the third tree identifies the clinical findings related to
COVID-19. Li et al. [32] explore the use of a convolutional
siamese neural network-based algorithm for the estimation
of pulmonary disease severity on chest X-ray images from
patients with COVID-19 in order to predict subsequent intu-
bation or death. This method can also be used for longitudinal
disease evaluation and risk stratification. In the work of
Khan et al. [33], the authors present CoroNet, a deep learning
method for the automatic COVID-19 detection in chest X-ray
images considering the binary classification COVID-19 vs
no-findings and the multi-class classification into the cate-
gories no-findings, pneumonia, and COVID-19. Data aug-
mentation and transfer learning techniques are also used in
order to overcome the limited size of some datasets and take
the most use of the available data. Therefore, in the work of
Waheed et al. [34], the authors present CovidGan, a method
based on a Classifier Generative Adversarial Network that
allows generating synthetic chest X-ray images in order to
enhance the performance of a Convolutional Neural Network
for COVID-19 detection. Narin et al. [35] evaluates three
different approaches using convolutional neural networks
based on transfer learning for the detection of pneumo-
nia associated with COVID-19 in the chest X-ray images.
In the work of Dansana et al. [36], the authors pro-
posed an automatic methodology for the early diagnosis of
COVID-19 patients using X-ray images of the chest
and CT scan images collected from different sources.
Minaee et al. [37] explores 4 state-of-the-art convolutional
networks for the COVID-19 detection using transfer learning
over a combined dataset generated from different publicly
available datasets. In the work of Basu et al. [38], the authors
present a method based on transfer learning called Domain
Extension Transfer Learning that tunes a model pre-trained
on a related large chest X-ray dataset for the classification
into the classes normal, other diseases, pneumonia, and
COVID-19.
Although the methods that were proposed in the litera-
ture provided good results, most of these approaches use
a very small dataset, COVID-ChestXRay [39], which con-
sists of 123 COVID-19 cases. In particular, these images
were obtained from highly heterogeneous equipment from all
around the world. As a consequence of having a very little and
heterogeneous data set, the test set sizes are extremely limited
and do not provide any statistical certainty about the learning.
In addition, to build negative COVID-19 cases, data samples
are typically taken from other datasets (mostly, from the
RSNA Pneumonia CXR challenge dataset on Kaggle [40]).
These images were obtained from the same X-ray equipment.
In this case, a deep learning model can group the X-ray
images according to the scanning equipment used for the
examination instead of the clinical findings associated with
the different conditions.
Furthermore, these datasets are mostly composed of
images captured by fixed X-ray equipment. The quality of
the chest X-ray images in terms of spatial resolution, con-
trast, presence of artifacts, or noise is conditioned by the
capture equipment and the acquisition technique [41], [42].
The nature of fixed equipment allows the optimization of
parameters such as the exposure time, the radiation field size,
or the orientation and distance of the X-ray tube, maximizing
the details of the perceived information content [41], [43].
However, in the context of the global pandemic caused by
COVID-19, a properly decontamination of the equipment
used for the acquisition of the chest X-ray images as well
as an effective control during the patient transport to the
X-ray room are critical factors in controlling the transmission
of the virus [44]. The use of portable equipment for the
acquisition of chest X-ray images allows to minimize the
patient transportation facilitating a more effective separation
of suspected patients with other low-risk cases [45]. In this
sense, the American College of Radiology (ACR) recom-
mends the use of portable chest X-ray acquisition equipment
in order to minimize the risk of cross-infection given the ease
of decontamination of the surface of portable devices and the
capability of acquiring the chest X-ray images in isolation
areas, avoiding the X-ray room or common areas such as
waiting rooms or hallways [46]. Although the use of portable
equipment entails a significant penalization in the quality
of the captured images [47], it has been the first and main
radiological analysis procedure in order to detect possible
findings that support the diagnosis of suspected patients,
as well as determine its severity, minimizing the risk of virus
transmission. Additionally, portable devices can also be very
effective for the triaging of patients with early symptoms but
instructed to stay at home if there are no severe signs, thus
avoiding the risk of the virus spreading and the collapse of
hospital centers. Furthermore, as the COVID-19 pandemic
progresses, there will be a greater reliance on portable devices
given their accessibility, widespread availability as well as
the reduced decontamination issues required for an adequate
use [44].
Given the great relevance and utility of the portable equip-
ment to face the public health emergency caused by the
COVID-19 pandemic, in this work, we propose a compre-
hensive methodology and derived accurate approaches for the
analysis of COVID-19 in the chest X-ray images acquired
by portable devices. To the best of our knowledge, it is the
first fully automatic methodology for the identification of
COVID-19 in the chest X-ray images acquired exclusively
through portable equipment. It is worth noting that the use of
portable units implies a greater challenge for the automatic
diagnostic of the COVID-19, given that the quality of the
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chest X-ray images in terms of spatial resolution, contrast,
or amount of perceived information is limited by the nature
of the portable equipment as well as the acquisition procedure
involved in this type of devices.
The proposed paradigm arises from the difficulty of dif-
ferentiating specific cases of COVID-19 from other respira-
tory affections and lung diseases that present similar clinical
conditions. In this context, a dataset has been specifically
designed for this analysis, including cases with COVID-19,
cases with lung conditions different from COVID-19, and
cases without lung pathologies. Therefore, the defined dataset
is divided into 3 clinical categories:Normal,Pathological and
COVID-19. It is worth mentioning that the considered patho-
logical cases are those from pulmonary diseases with similar
findings as COVID-19, whereas the normal subjects may not
be specifically healthy. In that case, they belong to healthy
patients as well as other pathological cases with character-
istics that differ from COVID-19. In that line, the proposed
work is applied to the most complex scenario of differentia-
tion to analyze the COVID-19 disease.
In order to emphasize the differentiation between these
three categories and explore the full potential of the avail-
able dataset, the proposed methodology integrates 3 com-
plementary approaches based on deep learning techniques.
The first of these approaches is aimed at classifying between
normal patients and those pathological cases that present
any indication that could be related to COVID-19, either
specifically related to the presence of COVID-19 or other
respiratory conditions with similar symptoms. The second
approach is specifically trained for the differentiation of the
patients with COVID-19 with respect to patients not infected
with COVID-19, whether normal cases or with respiratory
conditions other than COVID-19, but with similar symptoms.
Additionally, the third approach has been designed to deter-
mine the degree of separability between the 3 categories of
chest X-ray images considered in this work.
This way, the response of the first approach separates
healthy cases from pathological cases (including patients
with COVID-19), the response of the second approach
separates patients with COVID-19 from other individuals
(including healthy patients), whereas the response of the
third approach allows the separation between the 3 defined
categories, simultaneously. Thus, the combined use of the
responses from all the approaches allows reinforcing the dif-
ferentiation between COVID-19, pathological patients with
other similar respiratory conditions as well as other normal
cases. This way, it has the potential to increase the reliabil-
ity of the proposed system in the prognostic predictions to
triage and manage patient care. In that sense, in the clinical
collaboration contained in this contribution, the output of
all approaches are simultaneously provided to the clinical
specialists.
The dataset specifically designed for this study has been
provided by the Radiology Service of the Complexo Hospi-
talario Universitario A Coruña (CHUAC) that supplied the
assistance work of the radiology and computer services in
order to search for adapted solutions for the improvement in
the patient care. The evaluation of the prognostic performance
over this dataset showed that the proposed methodology and
designed approaches provide accurate results even though the
images acquired by portable devices present limited quality
conditions, allowing a reliable analysis to support the clinical
decision-making process in the context of this dramatic global
pandemic.
Summarizing, the main research highlights of the article
include:
• New computational approach for the classification of
chest X-ray images into 3 categories: normal, patholog-
ical, and COVID-19.
• First method specifically designed for the analysis of
COVID-19 in chest X-ray images acquired exclusively
by means of portable equipment.
• Methodology trained and validated over a dataset specif-
ically designed for this research.
• Accurate results even though portable devices acquire
images with poor quality conditions.
The manuscript is structured as follows: Section II
presents the dataset and describes the different deep learn-
ing approaches that were proposed in this research. Next,
Section III exposes all the conducted experiments whereas
Section IV discusses the obtained results. Then, Section V
describes the main limitations of this work. Finally,
Section VI presents the conclusions that are extracted from
this research as well as possible future work in the analysis
of this relevant disease.
II. MATERIALS AND METHODS
A. USED IMAGE DATASET
The used dataset was provided by the Radiology Service
of the Complexo Hospitalario Universitario A Coruña
(CHUAC). The protocols for this study have been reviewed
by the hospital board and are contained in an agreement with
the hospital management. The images have been acquired by
means of portable equipment, specifically, Agfa dr100E GE
and Optima Rx200 portable devices. These portable devices
were located in areas specifically intended for COVID-19 in
order to examine patients referred after undergoing triage in
the emergency systems and monitor these patients in the dif-
ferent hospital plants. The use of portable equipment allows
an effective separation between infected patients and patients
without suspected COVID-19, both in the radiology room
itself and in waiting rooms or hallways. For the acquisition
procedure, the patient lies in a supine position and a single
anterior-posterior projection is recorded. For this purpose,
the X-ray tube is connected to a flexible arm that is extended
over the patient to be exposed to a small dose of ionizing
radiation while an X-ray film holder or an image recording
plate is placed under the patient to capture images of the
interior of the chest.
The dataset consists of 1,616 chest X-ray images
divided into 728 normal cases corresponding to patients
who have neither pleural nor pulmonary pathologies
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FIGURE 1. Representative examples of chest X-ray radiographs. 1st row, chest X-ray radiographs from normal patients.
2nd row, chest X-ray radiographs from pathological patients without COVID-19 but diagnosed with other pleural or
pulmonary diseases. 3rd row, chest X-ray radiographs from patients with COVID-19.
(but other pathologies have not been assessed, such as car-
diology or hepatic diseases, for example) at the time of
image acquisition, 648 pathological cases corresponding
to patients without COVID-19 but diagnosed with other
pulmonary diseases that can present characteristics similar
to COVID-19i, as well as 240 specific COVID-19 cases.
Therefore, this dataset provides a very challenging scenario,
with a pathological category with diseases that are similar in
terms of characteristics to COVID-19 and normal subjects
that could present other non-related abnormalities. In any
case, the dataset presents cases that are very frequent in real
clinical practice scenarios.
Fig. 1 shows representative examples of chest X-ray
images related to the presented 3 clinical categories: normal,
pathological, and COVID-19.
B. COMPUTATIONAL APPROACHES FOR THE
CLASSIFICATION OF CHEST X-RAY IMAGES
The impact of COVID-19 on lung tissues can present simi-
larities with other patterns associated with some pulmonary
pathologies as common types of pneumonia, especially, dur-
ing the early stages of both respiratory conditions. In order
to enhance the differentiation of COVID-19 cases both from
cases that present clinical findings similar to COVID-19 and
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FIGURE 2. A general overview of the proposed paradigm. It receives as input chest X-ray images acquired through portable devices
and provides at the output the categorization of the images into the classes Normal, Pathological, or COVID-19.
from patients without respiratory conditions, 3 different
clinical categories were designed and considered. Thus,
the categoryNormal correspond to patients without pleural or
pulmonary pathologies, the category Pathological is related
to patients diagnosed with pleural or pulmonary patho-
logical conditions other than COVID-19, and the category
COVID-19 is specific for COVID-19 infected patients,
as stated in Section II-A.
In order to enhance the differentiation between the defined
clinical categories and exploit the full potential of the
designed dataset, the proposed computational methodology
integrates 3 different approaches based on deep learning
techniques for the classification of chest X-ray images.
A general overview of the proposed paradigm is depicted
in Fig. 2. It receives a chest X-ray image captured by the
portable device as input and provides its classification into
the classesNormal,Pathological, orCOVID-19. All proposed
approaches, herein presented, are detailed below:
1) NORMAL VS PATHOLOGICAL/COVID-19 APPROACH
Given the similarities between COVID-19 and other res-
piratory conditions, the first trained approach is aimed at
differentiating between patients with any abnormality in the
pulmonary tissues and patients with clinical findings in the
lungs, either due to COVID-19 or other respiratory condi-
tions. To this end, chest X-ray images associated with patho-
logical or COVID-19 cases are grouped under the same class
for the training procedure. Therefore, this approach predicts
2 different categories: Normal and Pathological/COVID-19.
2) NORMAL/PATHOLOGICAL VS COVID-19 APPROACH
The second trained approach is specifically intended to iden-
tify COVID-19 cases, differentiating them not only from nor-
mal cases but also from those pathological patients affected
by other respiratory conditions that manifest similar charac-
teristics, such as pneumonia. For this purpose, chest X-ray
images from normal patients and those from pathological
patients with respiratory conditions other than COVID-19 are
grouped in the same class, and, therefore, the approach pre-
dicts Normal/Pathological and COVID-19 categories.
3) NORMAL VS PATHOLOGICAL VS COVID-19 APPROACH
Additionally, we adapted a network architecture to specifi-
cally determine the degree of separability between the 3 cate-
gories of chest X-ray images considered in this work. To this
end, we trained a model with a set of chest X-ray images of
the 3 different categories: patients infected with COVID-19,
patients with other pathologies with similar characteristics to
COVID-19 and normal patients.
C. NETWORK ARCHITECTURE
Over the recent years, deep learning methods have demon-
strated to be an excellent technique in the area of artifi-
cial intelligence given its potential and ability to recognize
complex patterns from raw input data, learning proper
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TABLE 1. An illustration of the DenseNet-161 structure that was adapted for the experiments of this work.
hierarchical representations of the underlying information at
different levels. The great potential of these techniques is
increasingly used in many relevant fields of medical imag-
ing [48], [49], including computer-aided detection/diagnosis
systems and medical image analysis for accurate early detec-
tion, diagnosis, treatment and monitoring of many relevant
diseases [50], [51].
In this work, we exploit the potential of a densely con-
volutional network architecture inspired by the DenseNet
proposal of Huang et al. [52], which was adapted to our
issue due to its flexibility and simplicity and its preceding
promising results in other classification tasks applied to the
diagnosis of pulmonary diseases [53]–[55]. For this research,
the original structure of the DenseNet-161 architecture has
been adapted, as depicted in Table 1. Specifically, in this
architecture, each layer is connected to every other layer in a
feed-forward fashion within each dense block to ensure max-
imum information flow between layers. In order to preserve
the feed-forward nature, each layer processes feature maps
from all the preceding layers as separate inputs and transfers
its own feature maps to all subsequent layers. The classifi-
cation layer has been adapted to support the output defined
for each deep learning approach considered by this proposal,
that is, the categorization of chest X-ray images into 2 clinical
classes, considering normal or pathological categories in the
first approach and Non-COVID-19 or COVID-19 categories,
in the second approach.
D. TRAINING DETAILS
The dataset was randomly divided into three mutually exclu-
sive sets, trying to balance the number of chest X-ray images
associated with each category throughout the sets. In particu-
lar, this partition includes 60% of the cases for training, 20%
for validation, and the remaining 20% for testing.
For the training procedure, the weights from a model
pretrained on the ImageNet dataset have been used for the
dense network architecture initialization [56]. Thus, the pre-
trained model allows a more efficient learning process and
fast convergence since the weights are initially stabilized.
Additionally, it significantly reduces the amount of labeled
data required for an adequate model training, as is our case.
Each presented deep learning approach is trained end-
to-end with a cross-entropy loss function [57] over the output
class and the ground truth for the target chest X-ray image.
The optimization during the training stage is performed by
means of Stochastic Gradient Descent (SGD) with a constant
learning rate of 0.01, a mini-batch size of 4, and a first-order
momentum of 0.9. These values that were obtained under
different exhaustive experimentation are directly indicated
for simplicity. This optimizer, despite its simplicity, is highly
efficient for the discriminative learning of classifiers under
convex loss functions [58], defined in Equation 1:
L = −Y · log(Ŷ ) (1)
where Y represents the ground truth values and Ŷ represents
the estimated values for each identified category. A com-
plete training epoch includes a forward pass of all the target
frames composing the training set. Each training process was
performed throughout 200 epochs given that a higher num-
ber of epochs showed no significant improvements in both
cross-entropy loss and classification accuracy performances.
In order to assess the generalization capability of the pre-
sented deep learning approaches to extrapolate to unseen
chest X-ray images, 5 independent repetitions with a different
random selection of the sample divisions were performed,
being calculated the mean cross-entropy loss and the mean
accuracy to evaluate their global performance.
1) DATA AUGMENTATION
Despite the pretraining, given the dimensionality of the
dataset, data augmentation was performed in the experiments,
increasing the number of the training samples in order
to avoid overfitting and improve the generalization of
the network, obtaining more robust and stable trained
models [59], [60].
Thus, given the limited amount of COVID-19 subjects,
different configurations of affine transformations are applied
to the input chest X-ray images to increase the variability of
the training data and improve the performance of the convolu-
tional neural networks. In particular, considering the possible
resolutions provided by the common variety of acquisition
devices as well as the symmetrical nature of the human
body, several combinations of scalingwith horizontal flipping
operations were included throughout the training procedure.
E. EVALUATION
The performance of the presented approaches was evaluated
by comparing the predictions provided by the networks with
the ground truth labels annotated in the dataset. Then, using
as reference the True Positives (TP), True Negatives (TN),
False Positives (FP) and False Negatives (FN) extracted from
this comparison, several performance metrics, commonly
used in the literature to evaluate the suitability of com-
putational methods for medical imaging, were considered.
195600 VOLUME 8, 2020
J. de Moura et al.: Deep Convolutional Approaches for the Analysis of COVID-19 Using Chest X-Ray Images
Thus, Precision, Recall, F1-score, and Accuracy were com-
















+ FP+ FN (5)
III. EXPERIMENTAL RESULTS
In this section, we present the experimental results of the
proposed approaches for the classification of COVID-19 in
chest X-ray images. In order to explore the full potential of the
available dataset, 3 experiments that complement each other
were considered. The following sections detail the results for
each of the experiments.
A. 1st EXPERIMENT: ANALYZING THE NORMAL
VS PATHOLOGICAL/COVID-19 APPROACH
The first scenariowas designed in order to evaluate the perfor-
mance of the proposed approach to distinguish between chest
X-ray images of subjects with COVID-19 from other similar
pulmonary or pleural pathological conditions as well as other
non-related normal subjects. Accordingly, we designed an
experiment with a total of 1,616 chest X-ray images, being
240 from COVID-19, 648 from patients with other similar
lung diseases, and 728 from normal subjects. Therefore,
the binary classes Normal and Pathological/COVID-19 are
balanced, maintaining this proportion in the random divi-
sions in training, validation and testing sets. Figs. 3 and 4
show the performance that was achieved using the DenseNet
architecture after 5 independent repetitions in the training
and validation stages in terms of mean ± standard deviation
training accuracy and mean ± standard deviation training
loss, respectively.
In particular, as we can observe in Fig. 3, the best mean
accuracy obtained is 0.9219 ± 0.0810 for the training stage
in epoch 194 and the best average accuracy for the valida-
tion stage of 0.7783 ± 0.0260 in epoch 144. Additionally,
the proposed approach achieved its stability in the cross-
entropy function loss both for training and for validation after
epoch 150, as we can see in Fig. 4.
Table 2 presents a comparative analysis of the performance
at the test stage using precision, recall, and F1-scoremeasures
whereas Fig. 5 shows the corresponding confusion matrix.
As we can see, the proposed strategy achieves a global
accuracy of 79.62% using all the chest X-ray images of the
analyzed test dataset.
We would like to remark that the pathological combined
with the COVID-19 cases present a variety of diseases that
presents a significant variability of conditions in the lungs.
Also, normal subjects are those from healthy patients but
also from other pathological scenarios with characteristics
FIGURE 3. Mean ± standard deviation training and validation accuracy
after the 5 independent repetitions of the first experiment. A logarithmic
scale has been set to correctly display the values for a better
understanding of the results.
FIGURE 4. Mean ± standard deviation training and validation loss after
the 5 independent repetitions of the first experiment. A logarithmic scale
has been set to correctly display the values for a better understanding of
the results.
TABLE 2. Precision, recall, and F1-score results obtained at the test stage
for the classification of chest X-ray images between Normal vs
Pathological/COVID-19 cases.
different fromCOVID-19. Given that, we have to consider the
significant variability of characteristics that are represented
in both considered cases of this approach. As said, given
those circumstances as well as the low quality of the chest
X-ray images captured by portable devices, we consider that
this proposal is able to adequately distinguish pulmonary
pathological cases from normal patients.
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FIGURE 5. Confusion matrix for the classification of chest X-ray images
between Normal vs Pathological/COVID-19 cases at the test stage.
B. 2nd EXPERIMENT: ANALYZING THE NORMAL/
PATHOLOGICAL VS COVID-19 APPROACH
In this second experiment, we designed a complementary sce-
nario to evaluate the ability of the second analyzed approach
to distinguish between cases of patients with COVID-19 from
the rest of similar respiratory diseases or even normal
patients.
With this in mind, the proposed approach was validated
using a dataset composed of 720 chest X-ray images, being
240 from normal patients whereas other 240 from pulmonary
diseases and 240 from COVID-19 patients, respectively. This
way, we respect a proportion of 23 and
1
3 for the Normal/
Pathological and COVID-19 classes, trying to keep a mini-
mum of balance between both negative and positive classes of
this analyzed approach. These proportions were maintained
for the random divisions in the training, validation and testing
sets. In this case, those subjects with pulmonary diseases
and normal patients were randomly selected from the total
available in the used image dataset.
Figs. 6 and 7 illustrate the performance that was obtained
from the proposed deep neural architecture after 5 indepen-
dent repetitions in both the training and validation stages.
In particular, the proposed approach achieves a best average
accuracy of 0.9550± 0.0204 for training in epoch 166 and the
best average accuracy for validation of 0.8902 ± 0.0158 in
epoch 131, as we can see in Fig. 6.
In addition, the proposed approach achieved its stability
in the loss cross-entropy function both for training
and for validation after epoch 100, as we can see
in Fig. 7.
Table 3 summarizes the performance measurements that
were obtained by the proposed approach using the test
dataset, in terms of precision, recall, and F1-score for each
category, whereas Fig. 6 shows the corresponding confu-
sion matrix. As we can see, our approach shows a good
performance for both class Normal/Pathological and class
COVID-19, providing a global accuracy of 90.27%. In gen-
eral, the results are in line with the training performance being
the proposed approach able to classify chest X-ray images
FIGURE 6. Mean ± standard deviation training and validation accuracy
after the 5 independent repetitions of the second experiment.
A logarithmic scale has been set to correctly display the values for a
better understanding of the results.
FIGURE 7. Mean ± standard deviation training and validation loss after
the 5 independent repetitions of the second experiment. A logarithmic
scale has been set to correctly display the values for a better
understanding of the results.
TABLE 3. Precision, recall and F1-score results obtained at the test stage
for the classification of chest X-ray images between Normal/Pathological
vs COVID-19 cases.
between cases of patients with COVID-19 from other similar
pulmonary pathologies or normal subjects.
In this case, we have to consider that the separability
is more feasible. In particular, the positive class only con-
tains COVID-19 patients, with more restricted characteris-
tics, being the network capable of distinguishing them from
the rest of the subjects, outperforming the results of the first
approach.
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FIGURE 8. Confusion matrix for the classification of chest X-ray images
between Normal/Pathological vs COVID-19 cases at the test stage.
C. 3rd EXPERIMENT: ANALYZING THE NORMAL
VS PATHOLOGICAL VS COVID-19 APPROACH
The third scenario was designed in order to evaluate the
performance of the proposed approach to distinguish between
the 3 categories of chest X-ray images considered in this
work. In particular, we designed a complete experiment using
a total of 720 chest X-ray images, being 240 fromCOVID-19,
240 from patients with other similar lung or pleural diseases,
and 240 from normal subjects. The balance in the number of
chest X-ray images associated with each category was kept
for the random divisions in the training, validation and testing
sets. Figs. 9 and 10 show the performance that was achieved
using the network architecture after 5 independent repetitions
in the training and validation stages. As we can see, the best
mean accuracy that was produced is 0.8907 ± 0.0546 for the
training stage in epoch 160 and the best average accuracy for
validation of 0.7652 ± 0.0304 in epoch 75.
In Table 4, we can see the precision, recall, and F1-score
results obtained at the test stage, providing a global accuracy
of 79.86%. Complementary, Fig. 11 presents the confusion
FIGURE 9. Mean ± standard deviation training and validation accuracy
after the 5 independent repetitions of the third experiment. A logarithmic
scale has been set to correctly display the values for a better
understanding of the results.
FIGURE 10. Mean ± standard deviation training and validation loss after
the 5 independent repetitions of the third experiment. A logarithmic scale
has been set to correctly display the values for a better understanding of
the results.
TABLE 4. Precision, recall and F1-score results obtained at the test stage
for the classification of chest X-ray images between Normal vs
Pathological vs COVID-19 cases.
FIGURE 11. Confusion matrix for the classification of chest X-ray images
between Normal vs Pathological vs COVID-19 cases at the test stage.
matrix for the classification of chest X-ray images between
normal vs pathological vs COVID-19 cases at the test stage.
As we can see, all the results obtained show the robustness of
the proposed system in the classification of the 3 categories
of chest X-ray images considered in this work.
IV. DISCUSSION
Chest X-ray has become the first-line imaging modality used
for the identification of patients with COVID-19 infections
at an early stage when clinical symptoms may be nonspecific
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FIGURE 12. Representative examples of the generated gradient class activation maps based on predictions that illustrate parts
of the chest X-ray image that are strongly activated. 1st row, using the Normal vs Pathological/COVID-19 approach. 2nd row,
using the Normal/Pathological vs COVID-19 approach. 3rd row, using the Normal vs Pathological vs COVID-19 approach.
or sparse. In this context, portable radiography devices are
widely used by clinical specialists to evaluate suspected or
confirmed cases of COVID-19 disease directly on-site, with-
out the necessity of transferring patients potentially infected
by COVID-19 elsewhere. Therefore, this clinical procedure
helps to save critical time and resources for the therapeutic
process as well as reduce the risk of cross-infection.
In order to provide a visual interpretation of the proposed
approaches, we used the Gradient Class Activation Map
(Grad-CAM) [61] algorithm to generate the class activation
maps of the trained models, showing us what the neural
network sees and what it values when making its prediction.
As a result, the trained models were shown to be strongly
correlated with the clinical findings, as validated by the
clinical experts. In Fig. 12, we can see some representative
examples of the generated maps based on predictions that
illustrate parts of the chest X-ray image that are strongly
activated, as well as a considerable variability of the possible
scenarios represented in this research work such as the poor
contrast of the radiographs or the great similarity between
COVID-19 and others pulmonary diseases that are present in
our dataset.
To the best of our knowledge, these are the first fully
automatic approaches that were designed specifically for
the classification of COVID-19 using chest X-ray images
acquired only by portable equipment. Therefore, we cannot
make a direct comparison with other state-of-the-art methods.
In all scenarios, we have to consider the complexity of
analyzing chest X-ray images capture by portable devices,
which present a lower quality in comparison with other typ-
ically used images in many pulmonary computational pro-
posals using X-ray images. This poor quality is combined
with the complex tested scenarios of the dataset, considering
images from pulmonary conditions that may be confused
with the characteristics of COVID-19 as well as normal
subjects that include healthy subjects but also may include
other pathological conditions that are not related with the
characteristics of COVID-19. As said, the designed dataset
presents cases that are very frequent in real clinical practice
scenarios.
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Considering these complex scenarios of differentiation and
the poor quality of the analyzed images, the capabilities of
the adapted convolutional neural network offered an adequate
performance, distinguishing specifically the COVID-19 cases
from the rest, but also differentiating both COVID-19 and
pulmonary pathological cases from other normal cases,
a complex scenario with large variability in both negative and
positive classes.
V. LIMITATIONS OF THE STUDY
The use of portable equipment implies a greater challenge
for the automatic diagnostic of the COVID-19, given that the
acquired images present lower quality, being in the supine
position, providing a single anterior-posterior view, unlike
radiological analysis carried out in conventional rooms that
supplies 2 projections, anterior-posterior and lateral. Despite
the poor quality conditions of chest X-ray images acquired
by portable equipment, the obtained results show that the
proposed approaches allow a robust and reliable analysis to
support the clinical decision-making process in a real public
health emergency scenario. Despite this, the method presents
some intrinsic limitations due to the complex characteristics
that may be present in the X-ray images. Some cases of mis-
classification are due to poor contrast of X-ray images or the
presence of medical instruments such as endotracheal tubes,
orthopedic prosthetic devices, cardiac pacemakers, among
others. With an eye to the future, it would be necessary to
obtain more X-ray images including these specific cases in
order to provide a more comprehensive validation of the
proposed methodology.
VI. CONCLUSION
Coronavirus disease (COVID-19), caused by the newly dis-
covered severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is posing high pressure on healthcare services
worldwide given its drastic spreading. Therefore, the screen-
ing, early detection, and monitoring of the suspected individ-
uals are crucial to controlling the virus transmission. Given
the impact of COVID-19 in the pulmonary tissues, chest
radiography plays a main role in the examination of the man-
ifestations and patterns of lung abnormality associated with
the disease in order to support the diagnosis and determine its
severity. Furthermore, in the context of this global pandemic,
the use of portable equipment for the acquisition of chest
X-ray images represents the first and main radiological way
of analysis due to the more effective separation of the infected
patients, allowing to minimize the infection control issues
and, therefore, the risk of cross-contamination.
Thus, this work proposes a novel fully automatic method-
ology for the analysis of chest X-ray images acquired by
means of portable devices. Given the similarities between
COVID-19 and other pulmonary diseases that also affect
the lungs, the proposed methodology is composed of three
complementary deep learning approaches in order to bet-
ter analyze and differentiate different patients infected with
COVID-19, patients with other pathologies with similar char-
acteristics to COVID-19 and normal patients. Thus, the first
approach allows to classify between normal and pathological
patients, being pathological both patients with COVID-19
and patients with other similar respiratory conditions.
The second approach is aimed at differentiating between
patients with COVID-19 and patients that may be nor-
mal or present respiratory conditions other than COVID-19.
The third approach allows the classification between the
3 defined clinical categories, simultaneously. This way,
the joint response of all the approaches allows to classify and
better analyze the considered COVID-19, pathological and
normal cases.
The proposedmethodology and the tested approaches were
validated using a dataset provided by the Radiology Service
of the Complexo Hospitalario Universitario A Coruña
(CHUAC). To the best of our knowledge, it is the first pro-
posal specifically tailored for the classification of chest X-ray
images acquired exclusively by portable equipment. Despite
the poor quality conditions of these chest X-ray images,
the obtained results show that the proposed methodology and
the tested approaches allow a robust and reliable analysis to
support the clinical decision-making process in this context
of a public health emergency.
As future work, we plan to test the potential of the proposed
approaches using datasets acquired by portable equipment,
when publicly available, to provide a more complete valida-
tion with a screening scenario similar to that studied in this
work.
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